nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00289	0.00289	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Buprenorphine—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Buprenorphine—Rhinitis—Risedronate—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Buprenorphine—Sinusitis—Pamidronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Buprenorphine—Pharyngitis—Risedronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Buprenorphine—Angioedema—Alendronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Buprenorphine—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00278	0.00278	CcSEcCtD
Buprenorphine—Oedema peripheral—Risedronate—Paget's disease of bone	0.00277	0.00277	CcSEcCtD
Buprenorphine—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00276	0.00276	CcSEcCtD
Buprenorphine—Weight decreased—Zoledronate—Paget's disease of bone	0.00276	0.00276	CcSEcCtD
Buprenorphine—Urethral disorder—Risedronate—Paget's disease of bone	0.00275	0.00275	CcSEcCtD
Buprenorphine—Malaise—Alendronate—Paget's disease of bone	0.00275	0.00275	CcSEcCtD
Buprenorphine—Vertigo—Alendronate—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Buprenorphine—Infestation NOS—Zoledronate—Paget's disease of bone	0.00272	0.00272	CcSEcCtD
Buprenorphine—Infestation—Zoledronate—Paget's disease of bone	0.00272	0.00272	CcSEcCtD
Buprenorphine—Depression—Zoledronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Buprenorphine—Rhinitis—Pamidronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Buprenorphine—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Buprenorphine—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Buprenorphine—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Buprenorphine—Eye disorder—Risedronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Buprenorphine—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Buprenorphine—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00262	0.00262	CcSEcCtD
Buprenorphine—Tinnitus—Risedronate—Paget's disease of bone	0.00262	0.00262	CcSEcCtD
Buprenorphine—Urethral disorder—Pamidronate—Paget's disease of bone	0.00262	0.00262	CcSEcCtD
Buprenorphine—Cardiac disorder—Risedronate—Paget's disease of bone	0.00261	0.00261	CcSEcCtD
Buprenorphine—Myalgia—Alendronate—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Buprenorphine—Chest pain—Alendronate—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Buprenorphine—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Buprenorphine—Discomfort—Alendronate—Paget's disease of bone	0.00256	0.00256	CcSEcCtD
Buprenorphine—Angiopathy—Risedronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Buprenorphine—Immune system disorder—Risedronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Buprenorphine—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00253	0.00253	CcSEcCtD
Buprenorphine—Constipation—Etidronic acid—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Buprenorphine—Eye disorder—Pamidronate—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Buprenorphine—Bradycardia—Zoledronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Buprenorphine—Flushing—Pamidronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Buprenorphine—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Buprenorphine—Infection—Alendronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Buprenorphine—Mental disorder—Risedronate—Paget's disease of bone	0.00246	0.00246	CcSEcCtD
Buprenorphine—Malnutrition—Risedronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Buprenorphine—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00243	0.00243	CcSEcCtD
Buprenorphine—Angiopathy—Pamidronate—Paget's disease of bone	0.00242	0.00242	CcSEcCtD
Buprenorphine—Immune system disorder—Pamidronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Buprenorphine—Flatulence—Risedronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Buprenorphine—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Buprenorphine—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Buprenorphine—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Buprenorphine—Oedema peripheral—Zoledronate—Paget's disease of bone	0.0024	0.0024	CcSEcCtD
Buprenorphine—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.0024	0.0024	CcSEcCtD
Buprenorphine—Chills—Pamidronate—Paget's disease of bone	0.0024	0.0024	CcSEcCtD
Buprenorphine—Urethral disorder—Zoledronate—Paget's disease of bone	0.00239	0.00239	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00239	0.00239	CcSEcCtD
Buprenorphine—Back pain—Risedronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Buprenorphine—Muscle spasms—Risedronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Buprenorphine—Malnutrition—Pamidronate—Paget's disease of bone	0.00233	0.00233	CcSEcCtD
Buprenorphine—Erythema—Pamidronate—Paget's disease of bone	0.00233	0.00233	CcSEcCtD
Buprenorphine—Urticaria—Etidronic acid—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Buprenorphine—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Buprenorphine—Tension—Pamidronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Buprenorphine—Eye disorder—Zoledronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Buprenorphine—Dysgeusia—Pamidronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00227	0.00227	CcSEcCtD
Buprenorphine—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Buprenorphine—Flushing—Zoledronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Buprenorphine—Nervousness—Pamidronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Buprenorphine—Back pain—Pamidronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Buprenorphine—Muscle spasms—Pamidronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Buprenorphine—Angioedema—Risedronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Buprenorphine—Angiopathy—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Buprenorphine—Immune system disorder—Zoledronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Buprenorphine—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Buprenorphine—Vertigo—Risedronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Buprenorphine—Syncope—Risedronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Buprenorphine—Dyspepsia—Alendronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Buprenorphine—Chills—Zoledronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Buprenorphine—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00216	0.00216	CcSEcCtD
Buprenorphine—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Buprenorphine—Loss of consciousness—Risedronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Buprenorphine—Mental disorder—Zoledronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Buprenorphine—Agitation—Pamidronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Buprenorphine—Cough—Risedronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Buprenorphine—Constipation—Alendronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Buprenorphine—Pain—Alendronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Buprenorphine—Angioedema—Pamidronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Buprenorphine—Erythema—Zoledronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Buprenorphine—Malnutrition—Zoledronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Buprenorphine—Hypertension—Risedronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Buprenorphine—Malaise—Pamidronate—Paget's disease of bone	0.0021	0.0021	CcSEcCtD
Buprenorphine—Syncope—Pamidronate—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Buprenorphine—Chest pain—Risedronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Buprenorphine—Myalgia—Risedronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Buprenorphine—Arthralgia—Risedronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Buprenorphine—Dysgeusia—Zoledronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Buprenorphine—Anxiety—Risedronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Buprenorphine—Pruritus—Etidronic acid—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Buprenorphine—Back pain—Zoledronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Buprenorphine—Feeling abnormal—Alendronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Buprenorphine—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00204	0.00204	CcSEcCtD
Buprenorphine—Muscle spasms—Zoledronate—Paget's disease of bone	0.00204	0.00204	CcSEcCtD
Buprenorphine—Dry mouth—Risedronate—Paget's disease of bone	0.00204	0.00204	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Buprenorphine—Cough—Pamidronate—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Buprenorphine—Convulsion—Pamidronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Buprenorphine—Hypertension—Pamidronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Buprenorphine—Vision blurred—Zoledronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Buprenorphine—Diarrhoea—Etidronic acid—Paget's disease of bone	0.002	0.002	CcSEcCtD
Buprenorphine—Tremor—Zoledronate—Paget's disease of bone	0.00199	0.00199	CcSEcCtD
Buprenorphine—Infection—Risedronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Buprenorphine—Myalgia—Pamidronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Buprenorphine—Arthralgia—Pamidronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Buprenorphine—Urticaria—Alendronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Buprenorphine—Anxiety—Pamidronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Buprenorphine—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Buprenorphine—Abdominal pain—Alendronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Buprenorphine—Body temperature increased—Alendronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Buprenorphine—Shock—Risedronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Buprenorphine—Nervous system disorder—Risedronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Buprenorphine—Discomfort—Pamidronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Buprenorphine—Agitation—Zoledronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Buprenorphine—Angioedema—Zoledronate—Paget's disease of bone	0.00194	0.00194	CcSEcCtD
Buprenorphine—Skin disorder—Risedronate—Paget's disease of bone	0.00194	0.00194	CcSEcCtD
Buprenorphine—Malaise—Zoledronate—Paget's disease of bone	0.00192	0.00192	CcSEcCtD
Buprenorphine—Confusional state—Pamidronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Buprenorphine—Vertigo—Zoledronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Buprenorphine—Syncope—Zoledronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Buprenorphine—Oedema—Pamidronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Buprenorphine—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Buprenorphine—Infection—Pamidronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Buprenorphine—Palpitations—Zoledronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Buprenorphine—Shock—Pamidronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Buprenorphine—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Buprenorphine—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00186	0.00186	CcSEcCtD
Buprenorphine—Vomiting—Etidronic acid—Paget's disease of bone	0.00186	0.00186	CcSEcCtD
Buprenorphine—Cough—Zoledronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
Buprenorphine—Tachycardia—Pamidronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
Buprenorphine—Rash—Etidronic acid—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Buprenorphine—Convulsion—Zoledronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Buprenorphine—Dermatitis—Etidronic acid—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Buprenorphine—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Buprenorphine—Hypertension—Zoledronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Buprenorphine—Hypersensitivity—Alendronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Buprenorphine—Headache—Etidronic acid—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00182	0.00182	CcSEcCtD
Buprenorphine—Anorexia—Pamidronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Buprenorphine—Myalgia—Zoledronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Buprenorphine—Arthralgia—Zoledronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Buprenorphine—Chest pain—Zoledronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Buprenorphine—Insomnia—Risedronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Buprenorphine—Anxiety—Zoledronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Buprenorphine—Paraesthesia—Risedronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Buprenorphine—Discomfort—Zoledronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Buprenorphine—Asthenia—Alendronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Buprenorphine—Dyspnoea—Risedronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Buprenorphine—Hypotension—Pamidronate—Paget's disease of bone	0.00177	0.00177	CcSEcCtD
Buprenorphine—Dry mouth—Zoledronate—Paget's disease of bone	0.00177	0.00177	CcSEcCtD
Buprenorphine—Pruritus—Alendronate—Paget's disease of bone	0.00176	0.00176	CcSEcCtD
Buprenorphine—Dyspepsia—Risedronate—Paget's disease of bone	0.00176	0.00176	CcSEcCtD
Buprenorphine—Confusional state—Zoledronate—Paget's disease of bone	0.00175	0.00175	CcSEcCtD
Buprenorphine—Nausea—Etidronic acid—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Buprenorphine—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Buprenorphine—Oedema—Zoledronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Buprenorphine—Infection—Zoledronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Buprenorphine—Fatigue—Risedronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Buprenorphine—Insomnia—Pamidronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Buprenorphine—Pain—Risedronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Buprenorphine—Constipation—Risedronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Buprenorphine—Shock—Zoledronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Buprenorphine—Paraesthesia—Pamidronate—Paget's disease of bone	0.0017	0.0017	CcSEcCtD
Buprenorphine—Diarrhoea—Alendronate—Paget's disease of bone	0.0017	0.0017	CcSEcCtD
Buprenorphine—Nervous system disorder—Zoledronate—Paget's disease of bone	0.0017	0.0017	CcSEcCtD
Buprenorphine—Dyspnoea—Pamidronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Buprenorphine—Tachycardia—Zoledronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Buprenorphine—Somnolence—Pamidronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Buprenorphine—Skin disorder—Zoledronate—Paget's disease of bone	0.00168	0.00168	CcSEcCtD
Buprenorphine—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00168	0.00168	CcSEcCtD
Buprenorphine—Dyspepsia—Pamidronate—Paget's disease of bone	0.00167	0.00167	CcSEcCtD
Buprenorphine—Anorexia—Zoledronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Buprenorphine—Decreased appetite—Pamidronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Buprenorphine—Dizziness—Alendronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Buprenorphine—Fatigue—Pamidronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Buprenorphine—Pain—Pamidronate—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Buprenorphine—Constipation—Pamidronate—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Buprenorphine—Hypotension—Zoledronate—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Buprenorphine—Urticaria—Risedronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Buprenorphine—Vomiting—Alendronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Buprenorphine—Body temperature increased—Risedronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Buprenorphine—Abdominal pain—Risedronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Buprenorphine—Rash—Alendronate—Paget's disease of bone	0.00157	0.00157	CcSEcCtD
Buprenorphine—Insomnia—Zoledronate—Paget's disease of bone	0.00157	0.00157	CcSEcCtD
Buprenorphine—Dermatitis—Alendronate—Paget's disease of bone	0.00157	0.00157	CcSEcCtD
Buprenorphine—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Buprenorphine—Headache—Alendronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Buprenorphine—Paraesthesia—Zoledronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Buprenorphine—Dyspnoea—Zoledronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Buprenorphine—Somnolence—Zoledronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Buprenorphine—Dyspepsia—Zoledronate—Paget's disease of bone	0.00153	0.00153	CcSEcCtD
Buprenorphine—Decreased appetite—Zoledronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Buprenorphine—Abdominal pain—Pamidronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Buprenorphine—Body temperature increased—Pamidronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Buprenorphine—Fatigue—Zoledronate—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Buprenorphine—Constipation—Zoledronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Buprenorphine—Pain—Zoledronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Buprenorphine—Nausea—Alendronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Buprenorphine—Hypersensitivity—Risedronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Buprenorphine—Asthenia—Risedronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Buprenorphine—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00142	0.00142	CcSEcCtD
Buprenorphine—Pruritus—Risedronate—Paget's disease of bone	0.00141	0.00141	CcSEcCtD
Buprenorphine—Hypersensitivity—Pamidronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Buprenorphine—Urticaria—Zoledronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Buprenorphine—Abdominal pain—Zoledronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Buprenorphine—Body temperature increased—Zoledronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Buprenorphine—Diarrhoea—Risedronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Buprenorphine—Asthenia—Pamidronate—Paget's disease of bone	0.00136	0.00136	CcSEcCtD
Buprenorphine—Pruritus—Pamidronate—Paget's disease of bone	0.00134	0.00134	CcSEcCtD
Buprenorphine—Dizziness—Risedronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Buprenorphine—Diarrhoea—Pamidronate—Paget's disease of bone	0.0013	0.0013	CcSEcCtD
Buprenorphine—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Buprenorphine—Vomiting—Risedronate—Paget's disease of bone	0.00127	0.00127	CcSEcCtD
Buprenorphine—Rash—Risedronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Buprenorphine—Dermatitis—Risedronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Buprenorphine—Dizziness—Pamidronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Buprenorphine—Headache—Risedronate—Paget's disease of bone	0.00125	0.00125	CcSEcCtD
Buprenorphine—Asthenia—Zoledronate—Paget's disease of bone	0.00124	0.00124	CcSEcCtD
Buprenorphine—Pruritus—Zoledronate—Paget's disease of bone	0.00123	0.00123	CcSEcCtD
Buprenorphine—Vomiting—Pamidronate—Paget's disease of bone	0.00121	0.00121	CcSEcCtD
Buprenorphine—Rash—Pamidronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Buprenorphine—Dermatitis—Pamidronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Buprenorphine—Headache—Pamidronate—Paget's disease of bone	0.00119	0.00119	CcSEcCtD
Buprenorphine—Diarrhoea—Zoledronate—Paget's disease of bone	0.00119	0.00119	CcSEcCtD
Buprenorphine—Nausea—Risedronate—Paget's disease of bone	0.00119	0.00119	CcSEcCtD
Buprenorphine—Dizziness—Zoledronate—Paget's disease of bone	0.00115	0.00115	CcSEcCtD
Buprenorphine—Nausea—Pamidronate—Paget's disease of bone	0.00113	0.00113	CcSEcCtD
Buprenorphine—Vomiting—Zoledronate—Paget's disease of bone	0.0011	0.0011	CcSEcCtD
Buprenorphine—Rash—Zoledronate—Paget's disease of bone	0.00109	0.00109	CcSEcCtD
Buprenorphine—Dermatitis—Zoledronate—Paget's disease of bone	0.00109	0.00109	CcSEcCtD
Buprenorphine—Headache—Zoledronate—Paget's disease of bone	0.00109	0.00109	CcSEcCtD
Buprenorphine—Nausea—Zoledronate—Paget's disease of bone	0.00103	0.00103	CcSEcCtD
